Press Releases

A cultural mediation partnership between the Louvre and L'Oréal on beauty, its practices, its representations, and its role through ages and cultures

Paris, October 17, 2024 - Today at the Skin Alliance Forum, the Dermatological Beauty division of L’Oréal Groupe and the International League of Dermatological Societies (ILDS) announced a landmark study into the availability and accessibility of dermatological services in 194 countries.

Clichy, September 12, 2024 - L’Oréal today announces a tri-party agreement with biotech innovator, Abolis Biotechnologies and global specialty manufacturer, Evonik, to enable the discovery, development and manufacturing of innovative and sustainable ingredients for beauty products and beyond.

Clichy, 9th September 2024 – L’Oréal has been recognized for its commitment to diversity, equity and inclusion, securing the fifth position globally in this year’s prestigious FTSE Diversity & Inclusion Index Top 100 companies list.

Clichy, August 5th, 2024 - L’Oréal today announces the acquisition of a 10% stake in Galderma Group AG from Sunshine SwissCo AG (a consortium led by EQT), Abu Dhabi Investment Authority (ADIA), Auba Investment Pte. Ltd. (all acting in coordination as sellers), for a non-disclosed amount

Clichy, 1 August 2024 - L’Oréal announces that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2024.

Clichy, 3 June 2024 – L’Oréal today announces the launch of its fourth Employee Share Ownership Plan, allowing employees to purchase shares in L’Oréal and more closely participate in its development. In 2024, the plan will be rolled out in all countries where it is feasible (63 in total) and features enhanced accessibility for employees recently joining the Groupe.

L’ORÉAL ACCELERATES BEAUTY TECH LEADERSHIP WITH ADVANCED BIOPRINTED SKIN TECHNOLOGY AND GEN AI CONTENT LAB TO AUGMENT CREATIVITY

Clichy, 11 March 2024 – L’Oréal Groupe today announced the launch of MelasylTM, a breakthrough molecule designed to address localized pigmentation issues that lead to age spots and post-acne marks. According to a landmark, worldwide epidemiological study on pigmentary disorders, half of all people report having at least one skin pigmentation issue.